The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease

被引:29
|
作者
Velasco, Nicolas [1 ]
Contreras, Alvaro [1 ]
Grassi, Bruno [1 ]
机构
[1] Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago, Chile
关键词
diet therapy; fatty liver; liver diseases; Mediterranean diet; nonalcoholic fatty liver disease; METABOLIC SYNDROME; RISK; ADHERENCE; PATTERN; CANCER; INDIVIDUALS; IMPROVES; OBESITY;
D O I
10.1097/MCO.0000000000000071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The purpose of this review is to present the pathophysiological mechanisms and most recent clinical evidence regarding the role of the Mediterranean diet in preventing and treating nonalcoholic fatty liver disease (NAFLD). Recent findings Several components of the Mediterranean diet have proven benefits in controlling the pathophysiological mechanisms involved in NAFLD. However, the few clinical studies that have assessed the diet have involved low numbers of patients and lacked methodological rigor. The results of these studies suggest that the Mediterranean diet attenuates the progression of NAFLD once it is established, but does not contribute to preventing the disease in patients at risk. Summary Although there is a lack of clinical evidence derived from studies with high-quality methodology, the pathophysiological mechanisms of NAFLD shared with other associated pathologies suggest that there is a role for the Mediterranean diet in managing NAFLD. Studies with better methodology are needed to confirm the impact of the diet.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 50 条
  • [1] Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
    Luukkonen, Panu K.
    Dufour, Sylvie
    Lyu, Kun
    Zhang, Xian-Man
    Hakkarainen, Antti
    Lehtimaki, Tiina E.
    Cline, Gary W.
    Petersen, Kitt Falk
    Shulman, Gerald I.
    Yki-Jarvinen, Hannele
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (13) : 7347 - 7354
  • [2] Mediterranean diet and nonalcoholic fatty liver disease
    Anania, Caterina
    Perla, Francesco Massimo
    Olivero, Francesca
    Pacifico, Lucia
    Chiesa, Claudio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (19) : 2083 - 2094
  • [3] Mediterranean diet and nonalcoholic fatty liver disease
    Caterina Anania
    Francesco Massimo Perla
    Francesca Olivero
    Lucia Pacifico
    Claudio Chiesa
    World Journal of Gastroenterology, 2018, 24 (19) : 2083 - 2094
  • [4] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
    Koo, Seung-Hoi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (03) : 210 - 215
  • [5] MATERNAL NONALCOHOLIC FATTY LIVER DISEASE AND FETAL HEPATIC STEATOSIS: IS THERE A LINK?
    Klepper, Corie
    Trout, Andrew T.
    Popelar, Ann
    Durden, LaTea
    Stankiewicz, Traci E.
    Moreno-Fernandez, Maria E.
    Divanovic, Senad
    Xanthakos, Stavra A.
    DeFranco, Emily
    Mouzaki, Marialena
    HEPATOLOGY, 2022, 76 : S745 - S745
  • [6] Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
    AlShaalan, Rasha
    Aljiffry, Murad
    Al-Busafi, Said
    Metrakos, Peter
    Hassanain, Mazen
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02): : 64 - 70
  • [7] Health benefits of Mediterranean diet in nonalcoholic fatty liver disease
    Abenavoli, Ludovico
    Di Renzo, Laura
    Boccuto, Luigi
    Alwardat, Nuha
    Gratteri, Santo
    De Lorenzo, Antonino
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (09) : 873 - 881
  • [8] Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US
    Han, Aiguo
    Zhang, Yingzhen N.
    Boehringer, Andrew S.
    Montes, Vivian
    Andre, Michael P.
    Erdman, John W., Jr.
    Loomba, Rohit
    Valasek, Mark A.
    Sirlin, Claude B.
    O'Brien, William D., Jr.
    RADIOLOGY, 2020, 295 (01) : 106 - 113
  • [9] Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
    Xi, Yingfei
    Li, Hongshan
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [10] Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
    Lee, Hyo Young
    Jun, Dae Won
    Kim, Hyun Jung
    Oh, Hyunwoo
    Saeed, Waqar Khalid
    Ahn, Hyeongsik
    Cheung, Ramsey C.
    Nguyen, Mindie H.
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (02): : 296 - +